Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists an…
$0.64+2.19%
报价 2026-11-06
市值
$251M
EV
$120.1M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -62.1%
$0.60$1.68
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| LABStandard BioTools Inc. | $251M | +2.2% | +2.7% | 48.3% | – | – | – | |
| CBLLCeriBell, Inc. | $1.03B | +2.2% | +29.3% | 88.9% | – | – | – | |
| KIDSOrthoPediatrics Corp. | $829.3M | -1.4% | +12.9% | 73.8% | – | 364.7x | 253.5x | GARP |
| VREXVarex Imaging Corporation | $783M | -0.4% | +3.8% | 34.3% | 35.2x | 12.1x | – | |
| CTKBCytek Biosciences, Inc. | $757.8M | +8.0% | +6.0% | 53.2% | – | – | – | |
| BVSBioventus Inc. | $726.5M | -0.7% | +5.6% | 69% | 17.3x | 12.7x | 10.0x | |
| CGEMCullinan Therapeutics, Inc. | $695.1M | +4.7% | +142.3% | 0% | – | – | – | |
| SYSo-Young International Inc. | $268.1M | -1.9% | – | 46% | – | – | – | |
| TMCITreace Medical Concepts, Inc. | $262.1M | -3.6% | -2.7% | 79.5% | – | – | – | |
| 同行中位数 | – | – | +6.0% | 61.1% | 26.3x | 12.7x | 131.7x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。